Abstract: The present invention relates to a cubic element for construction toys, including three, straight, open-ended channels each formed on an adjacent different face of the cube between two opposite faces of the cube and extending in orthogonal opposite directions to each other (X,Y,Z). Each channel includes a bottom wall and two upwardly extending parallel sidewalls, wherein the width of the bottom wall and the distance between the face which is distal to the channel that is extending orthogonally from the same cube face, and the sidewall adjacent the distal face, are substantially equal.

Abstract: The present disclosure provides method and system determining an optimal set of operating parameters for desired clinical outcome. The method comprises to receive treatment or target skin data comprising skin characteristics associated with skin to be treated with an aesthetic treatment by the aesthetic skin treatment unit and preset operating parameters for performing the aesthetic treatment. Further, the treatment data is analyzed using plurality of trained models to predict plurality of sets of operating parameters for the aesthetic skin treatment unit to perform the aesthetic treatment. Using the plurality of sets of operating parameters, an optimal set of operating parameters is determined for performing the aesthetic treatment by the using the aesthetic skin treatment unit. By proposed system and method, accurate set of operation parameters may be predicted to achieve desired clinical outcomes, without human intervention.

Abstract: The present invention relates to a cubic element for construction toys, including three, straight, open-ended channels each formed on an adjacent different face of the cube between two opposite faces of the cube and extending in orthogonal opposite directions to each other (X,Y,Z). Each channel includes a bottom wall and two upwardly extending parallel sidewalls, wherein the width of Fa the bottom wall and the distance between the face which is distal to the channel that is extending orthogonally from the same cube face, and the sidewall adjacent the distal face, are substantially equal.

Abstract: An in-vivo device may be propelled in the gastrointestinal tract by a magnetic force such that the direction of the magnetic force applied to the in-vivo device follows, or is continually adapted to, the instantaneous spatial orientation of the in-vivo device. As the in-vivo device changes orientation in the gastrointestinal tract by the wall of the gastrointestinal tract, so does the magnetic force, to follow suit.

Abstract: An in vivo sensing device and system may contain or be used in conjunction with an image sensor and a body lumen clearing element or agent. A method may enable clearing a body lumen for in vivo sensing while using the device of the invention.

Abstract: An in-vivo device may be propelled in the gastrointestinal tract by a magnetic force such that the direction of the magnetic force applied to the in-vivo device follows, or is continually adapted to, the instantaneous spatial orientation of the in-vivo device. As the in-vivo device changes orientation in the gastrointestinal tract by the wall of the gastrointestinal tract, so does the magnetic force, to follow suit.

Abstract: In-vivo devices, systems and methods for the detection of blood within in-vivo bodily fluids. The methods include irradiating in-vivo fluids passing through a gap in a housing of an in-vivo device introduced to the GI tract of a subject with a plurality of illumination sources positioned on a first side of a gap; detecting with at least one light detector positioned on the opposite side of the gap and facing the illumination sources, light irradiated by the illumination sources; transmitting a plurality of values representing the light detected over time; converting these values to blood concentration values over time, and comparing the blood concentration values to a predetermined threshold value. Based on the comparison, the method includes determining the type of bleeding profile, such that if a plurality of blood concentration values measured consecutively is above the threshold value, the bleeding profile indicates bleeding.

Abstract: A system and method for indicating transferability of a non-dissolvable target in-vivo device through the GI tract are described. The in vivo system includes a dissolvable in-vivo device which has two operational phases; an initial phase in which the device is of initial dimensions and a final phase in which the device is of final dimensions. In the initial phase the device can pass freely through a normally configured body lumen whereas it may not be able to pass freely through an abnormally configured lumen. In the final phase the device can pass freely through a body lumen even if it is abnormally configured.

Abstract: The invention relates to an in vivo sensing device having a specific gravity of about 1 or a volume to weight ratio that enables it essentially to float. In one embodiment the in vivo sensing device consists of an image sensor system and a buoyant body. The buoyant body, which is attached to the sensor system or which can optionally house one or more elements of the sensor system, keeps the sensor system essentially floating in a body lumen liquid.

Abstract: This invention relates to a system and methods for determining the initiation and/or the termination of an autonomous in vivo imaging procedure, such as by a capsule imaging the gastro intestinal tract.

Abstract: A swallowable in vivo therapeutic device, and a method for use of a device. The device may include a transparent case and one or more radiation sources, the radiation sources to treat the detected pathological lesions inside the gastrointestinal (GI) tract with light during the passage of the device through the GI tract. A method may include inserting into a patient a device, rotating external magnets in close proximity to the patient, thereby fully controlling the movement of the device inside the GI tract, stopping the device and activating the light radiation in areas of the pathological lesions for a predetermined period of time, and deactivating the light radiation and moving the device further through the GI tract.

Abstract: A device and system for in-vivo sensing having a relatively heavy part and a relatively light part such that the heavy and light part may be temporarily attached in-vivo. Detachment of the heavy part may be provided at a predetermined location along a body lumen. The light part upon detachment of the heavy part may for example float within a body lumen.

Abstract: An in vivo sensing device and system may contain or be used in conjunction with an image sensor and a body lumen clearing element or agent. A method may enable clearing a body lumen for in vivo sensing while using the device of the invention.

Abstract: The present invention discloses a system comprising an in vivo imaging device able to transmit in vivo data via a wireless medium, a receiver to receive in vivo data via the wireless medium, input means for entering to the receiver indications by a user, an indication storage unit to store the indications and to store data representing entering time at which the indications was entered by the user and information identifying in vivo data portions corresponding to that entering time, and a display unit to display the indications concurrently with the in vivo data portions corresponding to the entering time at which the indications was entered. The indications entered by the user may be indicative of activities of the user, condition of the user, environmental conditions next to the user and the like.

Abstract: A system and method to model a tracking curve of an in-vivo device capturing in-vivo data of the colon is provided. Data analysis is performed on a raw tracking curve to identify one or more milestone data points that correspond to defined locations in the colon. A modeled path may be defined between and along the selected milestone data points. Raw tracking curve data may be translated to modeled data along the modeled path. The modeled tracking curve may be displayed alongside a streaming display of captured in-vivo image frames of the colon.

Abstract: A system and method for indicating transferability of a non-dissolvable target in-vivo device through the GI tract are described. The in vivo system includes a dissolvable in-vivo device which has two operational phases; an initial phase in which the device is of initial dimensions and a final phase in which the device is of final dimensions. In the initial phase the device can pass freely through a normally configured body lumen whereas it may not be able to pass freely through an abnormally configured lumen. In the final phase the device can pass freely through a body lumen even if it is abnormally configured.

Abstract: A method for in vivo sensing of a body lumen such as a lumen in the upper GI tract is provided. The method may include, for example, inserting a sensing device into a subject's body lumen, positioning the subject in a horizontal or other suitable position, and receiving data transmitted from the sensing device.

Abstract: This invention relates to a system and methods for determining the initiation and/or the termination of an autonomous in vivo imaging procedure, such as by a capsule imaging the gastro intestinal tract.

Abstract: A device, a system and a method for in-vivo examination. A method for in-vivo examination includes substantially emptying a subject's colon from content, and inserting an autonomous in-vivo imaging device into the subject's gastrointestinal tract. An in-vivo examination kit includes an autonomous in-vivo imaging device, a wireless receiver, an antenna set, a laxative, and optionally a stimulant and an instructions leaflet.

Abstract: A system and method to model a tracking curve of an in-vivo device capturing in-vivo data of the colon is provided. Data analysis is performed on a raw tracking curve to identify one or more milestone data points that correspond to defined locations in the colon. A modeled path may be defined between and along the selected milestone data points. Raw tracking curve data may be translated to modeled data along the modeled path. The modeled tracking curve may be displayed alongside a streaming display of captured in-vivo image frames of the colon.